A biopharmaceutical research and development company engaged in developing human therapeutic products based primarily upon its small molecule molecular chaperone co-induction technology.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Current clinicals , existing documented cases under compassionary use. Shall we be honest all Bio stocks come with risk but IMO this team is close...call it Speculation but IMO well timed...phase 1 target 2.35. Disclosure: You should always assume anytime someone talks about a stock that they are long or short...LONG here.